Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyi Ye

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2017
Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Fatao Liu, Yi Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2020
Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitorsYing Cheng, Lixia Ma, Ying Liu, et al.
BMC Neuroscience|February 22, 2014
DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiationXiaoling Weng, Daizhan Zhou, Fatao Liu, et al.
Translational Lung Cancer Research|September 21, 2020
Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosisBin Zhang, Lianmin Zhang, Dongsheng Yue, et al.
Plos One|January 28, 2014
A genome-wide association study identifies a locus on TERT for mean telomere length in Han ChineseYun Liu, Lan Cao, Zhiqiang Li, et al.
Cancer Biology & Medicine|October 1, 2019
Prevalence and clinical significance of pathogenic germline <i>BRCA1</i>/<i>2</i> mutations in Chinese non-small cell lung cancer patientsXingsheng Hu, Dongyong Yang, Yalun Li, et al.
Cancer Biology & Medicine|June 27, 2020
Erratum to Prevalence and clinical significance of pathogenic germline <i>BRCA1/2</i> mutations in Chinese non-small cell lung cancer patientsXingsheng Hu, Dongyong Yang, Yalun Li, et al.
Cancer Science|February 19, 2019
Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancersLibo Yang, Feng Ye, Longlong Bao, et al.
Theranostics|July 21, 2020
The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung AdenocarcinomaLu Yang, Jing Zhang, Guangjian Yang, et al.
The Oncologist|August 31, 2018
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) <i>EGFR</i> Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II StudyLiwen Xiong, Rong Li, Jiayuan Sun, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2017
Genome-wide DNA Methylation Analysis Reveals <i>GABBR2</i> as a Novel Epigenetic Target for <i>EGFR</i> 19 Deletion Lung Adenocarcinoma with Induction Erlotinib TreatmentXiaomin Niu, Fatao Liu, Yi Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2020
Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitorsYing Cheng, Lixia Ma, Ying Liu, et al.
BMC Neuroscience|February 22, 2014
DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiationXiaoling Weng, Daizhan Zhou, Fatao Liu, et al.
Translational Lung Cancer Research|September 21, 2020
Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosisBin Zhang, Lianmin Zhang, Dongsheng Yue, et al.
Plos One|January 28, 2014
A genome-wide association study identifies a locus on TERT for mean telomere length in Han ChineseYun Liu, Lan Cao, Zhiqiang Li, et al.
Cancer Biology & Medicine|October 1, 2019
Prevalence and clinical significance of pathogenic germline <i>BRCA1</i>/<i>2</i> mutations in Chinese non-small cell lung cancer patientsXingsheng Hu, Dongyong Yang, Yalun Li, et al.
Cancer Biology & Medicine|June 27, 2020
Erratum to Prevalence and clinical significance of pathogenic germline <i>BRCA1/2</i> mutations in Chinese non-small cell lung cancer patientsXingsheng Hu, Dongyong Yang, Yalun Li, et al.
Cancer Science|February 19, 2019
Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancersLibo Yang, Feng Ye, Longlong Bao, et al.
Theranostics|July 21, 2020
The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung AdenocarcinomaLu Yang, Jing Zhang, Guangjian Yang, et al.
The Oncologist|August 31, 2018
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) <i>EGFR</i> Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II StudyLiwen Xiong, Rong Li, Jiayuan Sun, et al.
Pageof 7